Candid Therapeutics
Operator of a biotechnology research designed to create novel, easy-to-administer therapies for autoimmune diseases. The company offers advanced T-cell engager antibodies, precisely redirecting T-cell...
Valuation
$657M
Latest known
Share Price
N/A
Total Raised
$445M
Last Round
N/A